The RADxSM Tech Process: Accelerating Innovation for COVID-19 Testing.
IEEE Pulse
; 12(3): 21-23, 2021.
Article
in English
| MEDLINE | ID: covidwho-1280250
ABSTRACT
In the wake of the COVID-19 pandemic, the need for rapid and accurate diagnostic testing across populations quickly became evident. In response, the National Institutes of Health (NIH) was determined not only to invest heavily in this area but to change the process by which grant proposals were reviewed and funded in order to spur faster development of viable technologies. The Rapid Acceleration of Diagnostics (RADx) initiative was designed to speed innovation, commercialization, and implementation of potential COVID-19 diagnostic technology. As part of this effort, the RADx Tech initiative focuses on the development, validation, and commercialization of innovative point-of-care, home-based, and clinical lab-based tests that can detect SARS-CoV-2. This effort was enabled through the NIH's National Institute of Biomedical Imaging and Bioengineering (NIBIB) Point-of-Care Technology Research Network (POCTRN).
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Biomedical Engineering
/
Point-of-Care Systems
/
Pandemics
/
COVID-19 Testing
/
SARS-CoV-2
/
COVID-19
/
National Institutes of Health (U.S.)
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
IEEE Pulse
Journal subject:
Biomedical Engineering
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS